Note 11. Warrants

Common Stock Warrant Liability

In September 2009, the Company closed a registered direct offering with a select group of institutional investors that raised gross proceeds of $7.1 million and net proceeds of $6.3 million. In connection with this registered direct offering, the Company issued 2,018,153 shares of its common stock and warrants to purchase 1,009,076 shares of common stock. The warrants have an exercise price of $5.24 per share and are exercisable at any time on or after the six month anniversary of the date of issuance and on or prior to 66 months after the date of issuance. Under the terms of the warrants, upon certain transactions, including a merger, tender offer or sale of all or substantially all of the assets of the Company, each warrant holder may elect to receive a cash payment in exchange for the warrant, in an amount determined by application of the Black-Scholes option valuation model. Accordingly, pursuant to ASC 815.40, Derivative Instruments and Hedging - Contracts in Entity's Own Equity, the warrants are recorded as a liability and then marked to market each period through the Statement of Operations in other income or expense. At the end of each subsequent quarter, the Company will revalue the fair value of the warrants and the change in fair value will be recorded as a change to the warrant liability and the difference will be recorded through the Statement of Operations in other income or expense.

The fair value of the warrants at March 31, 2012 and December 31, 2011 was $88,798 and $166,397, respectively, calculated using the Black-Scholes option-pricing model with the following assumptions:

	March 31, 2012			December 31, 2011

Risk-free interest rate		1.04	%		0.83	%
Expected volatility		60.0	%		75.17	%
Expected life (in years)		1.5			1.6
Expected forfeiture rate		0.0	%		0.0	%
Expected dividend yield		0.00	%		0.00	%

As a result of this adjustment, the Company recorded a non-cash benefit of $77,600 in the three months ended March 31, 2012. The following is a summary of the changes in the common stock warrant liability for the three months ended March 31, 2012:

Beginning balance, January 1, 2012	$	166,398
Issuances		-
Gain from the adjustment for the change in fair value included in net loss		(77,600	)
Ending balance, March 31, 2012	$	88,798

Common Stock Warrants

As a result of equity financings in 2009 through 2011, the Company had 11,598,617 warrants outstanding and exercisable as of March 31, 2012. The warrants had a weighted average exercise price of $3.15 and a weighted average remaining contractual term of 4.7 years.